Gals Bio

Gals Bio is pioneering a new category in women’s health and wellness called Fem-Wearables.

Health Tech & Life Sciences
Active
Pre-Seed Mevaseret Zion, Israel Founded 2015
Last updated 2026-06-18
Total raised
$2.0M
Last: 2022-01
Stage
Pre-Seed
Founded
2015
Headcount
6
HQ
Mevaseret Zion, Israel
Sector
Health Tech & Life Sciences

About

Gals Bio is pioneering a new category in women’s health and wellness called Fem-Wearables. By leveraging the unique vaginal environment and integrating AI-powered analysis, we provide personalized, early, and accessible home health solutions that are accurate, affordable, and designed for early-stage detection. These solutions include rapid screening, monitoring, and therapeutic care for women’s health needs.

Tulipon our first device enables clean collection of vaginal secretions for cancer screening. Women of any age with abnormal bleeding, BRCA mutations, or high cancer risk can use Tulipon for up to 12 hours. Its liquid-lock mechanism preserves the sample, which is then sent to a lab for AI-powered liquid biopsy analysis. Tulipon minimizes human interference, preventing errors and contamination. Its absorbent-free design ensures access to all fluids and tissue secretions, empowering early detection, convenience, and proactive reproductive health diagnostics.

Funding history · 2 rounds · $2.0M total

2022-01
$463K
2016-04
$1.5M

Q&A

What is Gals Bio's primary focus?
Gals Bio is pioneering Fem-Wearables, a new category in women’s health and wellness, providing personalized, early, and accessible home health solutions through AI-powered analysis of the vaginal environment.
What is Tulipon and its purpose?
Tulipon is Gals Bio's first device, designed for the clean collection of vaginal secretions for cancer screening. It uses a liquid-lock mechanism to preserve samples for AI-powered liquid biopsy analysis, aiming for early detection and proactive reproductive health diagnostics.
When was Gals Bio founded?
Gals Bio was founded in October 2015.
What is the total amount of funding Gals Bio has raised to date?
Gals Bio has raised a total of $1,963,000 USD.
When was Gals Bio's most recent funding round and who invested?
Gals Bio's most recent funding round occurred in January 2022, with investment from PipelBiz.
Who is the Founder and CEO of Gals Bio?
Hilla Shaviv is the Founder & CEO of Gals Bio.
What is Gals Bio's primary sector?
Gals Bio's primary sector is Health Tech & Life Sciences.
What is the product stage of Gals Bio's offerings?
Gals Bio's product is currently in the clinical trial stage.

Team · 1

Founder · Founder & CEO
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesDiagnostics DevicesDigital HealthcareDigital Medical Diagnostics
Technologies
Materials & SubstancesPolymersSensing
Target customers
ConsumersDemographics & FamilyWomenHealthcare & Life SciencesHealthcareProvidersPatients
Business model
B2B2CB2CB2B

Highlights

1 PatentsVerified

Tags

wellnessmedical-technologiesbiomarkersmedical-devicesnon-invasivemedicationmonitoringbiodegradablemedical-productswomendata-analyticsmobile-applicationssensorswomen-healthdigital-healthcarelifestylediagnosticshome-carehygienemhealthcancerblood-testwearable
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)